American Pharmacy News
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • People
  • Innovation
  • Regulatory
  • Industry
  • Federal Issues
  • State Issues
  • Directory
  • Home
  • »
  • Stories
  • »
  • American Pharmacy News Reports

Concert moves towards agreement for cystic fibrosis assets

American Pharmacy News Reports | May 25, 2017
Concert may be able to receive $90 million in milestones if they receive regulatory approval.

Concert Pharmaceuticals Inc. has received a second request from the Federal Trade Commission for the acquisition of CTP-656, as well as other options for cystic fibrosis treatment, produced by Vertex Pharmaceuticals Inc. Read More »

Amgen presents new medication for migraines

American Pharmacy News Reports | May 25, 2017
The study took into account 2,600 patients suffering from migraines.

Amgen announced May 18 a Biologics License Application which they submitted to the U.S. Food and Drug Administration for a migraine prevention medication. Read More »

CVS promotes skin protection awareness month

American Pharmacy News Reports | May 25, 2017
CVS and Johnson & Johnson also are partnering with the American Cancer Society.

CVS Pharmacy is launching a new campaign during the month of May, by the name of Long Live Skin. Read More »

Omnicell unveils new dispensing system

American Pharmacy News Reports | May 25, 2017
The new software gives patients access to more capacity, faster service and higher security.

Omnicell Inc, announced May 1 that they would be allowing patients of AcuDose-Rx Automated Dispensing Cabinets the ability to upgrade to the more specialty XT Series while using their current software. Read More »

Good Day Pharmacy executive participates in steering committee

American Pharmacy News Reports | May 25, 2017
The National Community Pharmacists Association is made up of seven committees and one task force.

Good Day Pharmacy COO, Vicki Einhellig took place in the recent National Community Pharmacists Association's Steering Committee Forum from April 25-26. Read More »

Amgen promotes refund agreement for Repatha users

American Pharmacy News Reports | May 23, 2017
Repatha functions by inhibiting PCSK9.

Amgen announced May 2 that they had signed an outcome-based refund contract with Harvard Pilgrim for Amgen's Repatha. Read More »

BiologicTx marks milestone for donor/recipient matching technology

Carrie Bradon | May 23, 2017
The system ensures recipients will receive the best donation available.

BiologicTx marked a year of successful transplants using its paired donation software, BiologicTx MatchGrid. Read More »

PBMs changing the face of pharmacies

American Pharmacy News Reports | May 23, 2017
Specialty pharmacies harness the expertise of pharmacists, nurses, social workers and insurance professionals.

Pharmacy benefit managers are changing the way that prescriptions are filled, reducing the costs for patients and increasing the value for all involved. Read More »

Aytu BioScience posters link oxidative stress to infertility

American Pharmacy News Reports | May 23, 2017
ORP plays a role in the pathophysiology of varicocele associated infertility.

Aytu BioScience Inc. has two new posters that exhibit the use of the MiOXSYS System, a tool developed by the company for determining oxidative stress in human semen. Read More »

Takeda taps Biologics as specialty provider for cancer drug

American Pharmacy News Reports | May 23, 2017
Patients who suffer from NSCLC make up about 85 percent of lung cancer cases in the U.S.

Biologics Inc., a McKesson Specialty Health company, has been selected by Takeda Pharmaceutical Co. to be a “specialty pharmacy provider” for ALUNBRIG, a Takeda-manufactured drug for anaplastic lymphoma kinase positive metastatic non-small cell lung cancer. Read More »

Kalydeco approved to treat new cystic fibrosis strands

American Pharmacy News Reports | May 21, 2017
Kalydeco can now treat up to 33 CF mutations.

The drug Kalydeco was recently approved to treat additional case of gene mutations in cystic fibrosis patients, the U.S. Food and Drug Administration reported on May 17 in a press release. Read More »

FDA approves pediatric leukemia drug from Abon Pharmaceuticals

American Pharmacy News Reports | May 21, 2017
Clofarabine Injection is Abon Pharmaceuticals' third product to receive a patent.

The FDA recently approved Abon Pharmaceuticals' Abbreviated New Drug Application for its Clofarabine Injection as a treatment for pediatric patients who suffer from relapsed or refractory acute lymphoblastic leukemia, a deadly cancer disease. Read More »

Fred's Pharmacy screens over 98,000 for heart disease

American Pharmacy News Reports | May 21, 2017
Fred’s Pharmacy has donated over $130,703 to the American Heart Association.

fred’s Pharmacy was pleased to report they screened over 98,000 people for heart disease and detection during their Heart Disease Awareness and Colorectal Cancer Campaigns, and made a huge donation of $38,244 to the American Heart Association this month. Read More »

Pennsylvania officials meet to share opioid strategies

Ruth de Jauregui | May 21, 2017
Benzodiazepines are prescribed for a variety of conditions, including panic disorder and seizures.

Pennsylvania Physician General Dr. Rachel Levine and Dauphin County Coroner Graham Hetrick recently met to discuss prescribing guidelines for opioids and benzodiazepines, known as benzos, and the opioid epidemic. Read More »

Results on anti-malarial drug Tafenoquine accepted for publication

American Pharmacy News Reports | May 20, 2017
The study determined the maximum tolerated dosages of tafenoquine, which is an investigational antimalarial agent.

60 Degrees Pharmaceuticals' study findings on tafenoquine have been published in Travel Medicine and Infectious Disease. Read More »

Express Scripts integrates with myMatrixx to expand resources

American Pharmacy News Reports | May 20, 2017
Express Scripts recently released data showing the firm had lowered workers' compensation prescription drug spending by 7.6 percent in 2016.

Express Scripts has acquired myMatrixx to combine its integrated pharmacy benefit management services with myMatrixx's workers' compensation pharmacy benefits experience. Read More »

Sandoz partners with DURECT for development of non-opioid analgesic

Carrie Bradon | May 20, 2017
Sandoz will pay DURECT $20 million towards the development of the medication.

Sandoz AG, part of Novatis, has made an agreement with DURECT Corp. for the marketing of POSIMIR, an analgesic being developed by DURECT. Read More »

GE Healthcare joins forces with Check-Cap for cancer screening

American Pharmacy News Reports | May 20, 2017
Called the C-Scan system, a capsule scans the colon.

GE Healthcare is working alongside of Check-Cap on the development and validation of a cancer-screening process. Read More »

Portola to present at upcoming lymphoma conference in Switzerland

American Pharmacy News Reports | May 20, 2017
The study has tested cerdulatinib in individuals with relapsed/refractory b-cell malignancies.

Portola Pharmaceuticals Inc.'s clinical results from a study will be presented during the International Conference on Malignant Lymphoma. Read More »

2017 AFHS Drug Information compendium has been released

American Pharmacy News Reports | May 18, 2017
The AHFS DI includes a database of drug monographs.

The American Society of Hospital Pharmacists (ASHP) recently announced that a new AHFS Drug Information (AHFS DI) has been released. Read More »

  • «
  • 1
  • 2
  • ...
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • ...
  • 168
  • 169
  • »
Trending

Scott Newman, Chairman, Pharmacists United for Truth and Transparency

Pharmacists United for Truth and Transparency: PBMs are the ‘primary driver of high drug prices in the U.S.’

Dr. Gerard Acloque, Doctor for Florida Concierge Medicine & Wellness

Doctor on Eli Lilly compounding pharmacy lawsuit: 'We are now left with very little options outside the branded medications'

Sazan Sylejmani, Owner & Pharmacy Manager of Westmont Pharmacy

Monty's Home Medical highlights benefits of tailored compounded medications

Craig Brockie, Founder & CEO of Ultimate Health Solutions

Ultimate Health Solutions founder on Patients First: 'Our healthcare system doesn't reward health'

 Jeff Harrell Board President

NCPA comments on Trump's executive order concerning drug pricing

Copyright © 2025 American Pharmacy News. All Rights Reserved.

  • About
  • Contact
  • Privacy Policy
  • Terms of Service

Alerts Sign-up